News 17 Apr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 23 Ago 2023 Forty51 Ventures provides the financial backing to found Mysthera Therapeutics Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided 3.5 million US dol...
News 29 Feb 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 01 Mar 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
Industry Report 22 Feb 2024 Fintech in Kenya As part two of the regional fintech series after South Africa, this report delves into Kenya's fintech landscape. Marked by innovation, a proacti...
News 12 Dic 2023 PharmaBiome and Ferring agree cooperation PharmaBiome and the biopharmaceutical firm Ferring from the canton of Vaud will in future each jointly develop and manufacture specific bacterial...
Video 05 Dic 2023 The latest news from the Singapore FinTech Festival 2023 Couldn't make it to Singapore yourself this year? Don’t miss the news from the world’s largest fintech event. Hear Swiss peers and a renowned ind...